サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413326

硫酸キニジンの市場：投与経路、用途、エンドユーザー別-2024-2030年の世界予測

Quinidine Sulfate Market by Route of Administration (Intravenous, Oral), Application (Arrhythmias, Malaria), End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
硫酸キニジンの市場：投与経路、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

硫酸キニジン市場規模は2023年に127億9,000万米ドルと推計され、2024年には137億4,000万米ドルに達し、CAGR 6.30%で2030年には196億3,000万米ドルに達すると予測されます。

世界の硫酸キニジン市場

主な市場の統計
基準年[2023］ 127億9,000万米ドル
予測年[2024］ 137億4,000万米ドル
予測年 [2030] 196億3,000万米ドル
CAGR（%） 6.3%
硫酸キニジン Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは硫酸キニジン市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、硫酸キニジン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-硫酸キニジン市場の市場規模および予測は？

2-硫酸キニジン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-硫酸キニジン市場における技術動向と規制の枠組みは？

4-硫酸キニジン市場における主要ベンダーの市場シェアは？

5-硫酸キニジン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 不整脈やマラリアなどの他の病気の発生率の増加
      • 硫酸キニジンサプリメントについての人々の意識を高めるための政府の好ましい取り組み
      • 重度の熱帯熱マラリア原虫および過寄生虫血症を制御するためのキニジンの静脈内投与の普及率
    • 抑制要因
      • 殺虫剤耐性ベクターの入手可能性に関する問題
    • 機会
      • 医薬品の承認と硫酸キニジンの研究開発への投資の増加
      • 硫酸キニジン医薬品の進歩
    • 課題
      • 抗不整脈薬の使用増加による健康リスク
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 硫酸キニジンの市場：投与経路別

  • 静脈内
  • オーラル

第7章 硫酸キニジンの市場：用途別

  • 不整脈
  • マラリア

第8章 硫酸キニジンの市場：エンドユーザー別

  • 大人
  • 小児科

第9章 南北アメリカの硫酸キニジンの市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の硫酸キニジンの市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの硫酸キニジンの市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • 3M Company
    • Apotex Corporation
    • BUCHLER GmbH
    • ChemPoint
    • Inga Laboratories P. Ltd.
    • Merck KGaA
    • Novartis AG
    • Prism Industries Private Ltd.
    • PT Sinkona Indonesia lestar
    • Vital Laboratories Pvt. Ltd.
    • VIVAN Life Sciences Pvt. Limited
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. QUINIDINE SULFATE MARKET RESEARCH PROCESS
  • FIGURE 2. QUINIDINE SULFATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. QUINIDINE SULFATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. QUINIDINE SULFATE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. QUINIDINE SULFATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. QUINIDINE SULFATE MARKET DYNAMICS
  • FIGURE 7. QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 8. QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. QUINIDINE SULFATE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. QUINIDINE SULFATE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. QUINIDINE SULFATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. QUINIDINE SULFATE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 6. QUINIDINE SULFATE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. QUINIDINE SULFATE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. QUINIDINE SULFATE MARKET SIZE, BY ARRHYTHMIAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. QUINIDINE SULFATE MARKET SIZE, BY MALARIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 12. QUINIDINE SULFATE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. QUINIDINE SULFATE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. INDIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDONESIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. JAPAN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. MALAYSIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. PHILIPPINES QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. SINGAPORE QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SOUTH KOREA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. TAIWAN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. THAILAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. VIETNAM QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. DENMARK QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EGYPT QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. FINLAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FRANCE QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. GERMANY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. ISRAEL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ITALY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. NETHERLANDS QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NIGERIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NORWAY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. POLAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. QATAR QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. RUSSIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. SAUDI ARABIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH AFRICA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SPAIN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SWEDEN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWITZERLAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. TURKEY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED ARAB EMIRATES QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED KINGDOM QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. QUINIDINE SULFATE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 142. QUINIDINE SULFATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 143. QUINIDINE SULFATE MARKET LICENSE & PRICING
目次
Product Code: MRR-62667ADFACDF

[194 Pages Report] The Quinidine Sulfate Market size was estimated at USD 12.79 billion in 2023 and expected to reach USD 13.74 billion in 2024, at a CAGR 6.30% to reach USD 19.63 billion by 2030.

Global Quinidine Sulfate Market

KEY MARKET STATISTICS
Base Year [2023] USD 12.79 billion
Estimated Year [2024] USD 13.74 billion
Forecast Year [2030] USD 19.63 billion
CAGR (%) 6.3%
Quinidine Sulfate Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Quinidine Sulfate Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Quinidine Sulfate Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Quinidine Sulfate Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Apotex Corporation, BUCHLER GmbH, ChemPoint, Inga Laboratories P. Ltd., Merck KGaA, Novartis AG, Prism Industries Private Ltd., PT Sinkona Indonesia lestar, Vital Laboratories Pvt. Ltd., and VIVAN Life Sciences Pvt. Limited.

Market Segmentation & Coverage

This research report categorizes the Quinidine Sulfate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Intravenous
    • Oral
  • Application
    • Arrhythmias
    • Malaria
  • End-User
    • Adults
    • Pediatrics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Quinidine Sulfate Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Quinidine Sulfate Market?

3. What are the technology trends and regulatory frameworks in the Quinidine Sulfate Market?

4. What is the market share of the leading vendors in the Quinidine Sulfate Market?

5. Which modes and strategic moves are suitable for entering the Quinidine Sulfate Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Quinidine Sulfate Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in incidence of arrhythmia and other diseases, such as malaria
      • 5.1.1.2. Favorable government initiatives for increasing awareness among people about quinidine sulfate supplements
      • 5.1.1.3. Prevalence for intravenous quinidine to control severe P. Falciparum and hyperparasitemia
    • 5.1.2. Restraints
      • 5.1.2.1. Issues regarding availability of insecticide-resistant vectors
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing drug approvals and investments in R&D of quinidine sulfate
      • 5.1.3.2. Advancements in quinidine sulfate drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Health risks due to the increased use of antiarrhythmic drug
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Quinidine Sulfate Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intravenous
  • 6.3. Oral

7. Quinidine Sulfate Market, by Application

  • 7.1. Introduction
  • 7.2. Arrhythmias
  • 7.3. Malaria

8. Quinidine Sulfate Market, by End-User

  • 8.1. Introduction
  • 8.2. Adults
  • 8.3. Pediatrics

9. Americas Quinidine Sulfate Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Quinidine Sulfate Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Quinidine Sulfate Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. 3M Company
    • 13.1.2. Apotex Corporation
    • 13.1.3. BUCHLER GmbH
    • 13.1.4. ChemPoint
    • 13.1.5. Inga Laboratories P. Ltd.
    • 13.1.6. Merck KGaA
    • 13.1.7. Novartis AG
    • 13.1.8. Prism Industries Private Ltd.
    • 13.1.9. PT Sinkona Indonesia lestar
    • 13.1.10. Vital Laboratories Pvt. Ltd.
    • 13.1.11. VIVAN Life Sciences Pvt. Limited
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing